Research ArticleAutism Spectrum Disorder

GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models

See allHide authors and affiliations

Science Translational Medicine  03 Oct 2018:
Vol. 10, Issue 461, eaam8434
DOI: 10.1126/scitranslmed.aam8434

Article Information

vol. 10 no. 461

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication March 3, 2017
  • Resubmitted August 15, 2017
  • Accepted for publication December 15, 2017
  • .

Author Information

  1. Jamie Horder1,*,
  2. Max Andersson2,*,
  3. Maria A. Mendez1,
  4. Nisha Singh3,4,
  5. Ämma Tangen2,
  6. Johan Lundberg2,
  7. Antony Gee4,
  8. Christer Halldin2,
  9. Mattia Veronese3,
  10. Sven Bölte5,6,
  11. Lars Farde2,7,
  12. Teresa Sementa4,
  13. Diana Cash3,
  14. Karen Higgins3,
  15. Debbie Spain1,
  16. Federico Turkheimer8,
  17. Inge Mick8,
  18. Sudhakar Selvaraj8,
  19. David J. Nutt8,
  20. Anne Lingford-Hughes8,
  21. Oliver D. Howes9,
  22. Declan G. Murphy1,, and
  23. Jacqueline Borg2,5,
  1. 1Department of Forensic and Neurodevelopmental Sciences and Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK.
  2. 2Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm County Council, SE-171 76 Stockholm, Sweden.
  3. 3Department of Neuroimaging, Institute of Psychiatry Psychology, and Neuroscience, King’s College London, London, UK.
  4. 4Division of Imaging Sciences and Biomedical Engineering, King’s College London, London, UK.
  5. 5Center of Neurodevelopmental Disorders at Karolinska Institutet (KIND), Pediatric Neuropsychiatry Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden.
  6. 6Child and Adolescent Psychiatry, Center for Psychiatry Research, Stockholm County Council, Stockholm, Sweden.
  7. 7Personalised Healthcare and Biomarkers, AstraZeneca, PET Science Centre, Karolinska Institutet, Stockholm, Sweden.
  8. 8Neuropsychopharmacology Unit, Centre for Psychiatry, Division of Brain Sciences, Imperial College London, London, UK.
  9. 9Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK.
  1. Corresponding author. Email: declan.murphy{at}kcl.ac.uk
    • * These authors contributed equally to this work.

    • These authors contributed equally to this work.

    Altmetric

    Article usage

    Article usage: October 2018 to August 2019

    AbstractFullPdf
    Oct 20185317885455
    Nov 20183348059
    Dec 20182155442
    Jan 20191314436
    Feb 20191343545
    Mar 2019893433
    Apr 2019773621
    May 20191203813
    Jun 2019742417
    Jul 2019792322
    Aug 2019591415